Treatment of a high cardiovascular risk patient with McArdle's disease with PCSK9 inhibitors

2019 ◽  
Vol 31 (2) ◽  
pp. 89-92
Author(s):  
Victoria Marco-Benedí ◽  
Estíbaliz Jarauta ◽  
Sofía Pérez-Calahorra ◽  
Ana M. Bea ◽  
Fernando Civeira
Keyword(s):  
Cardiovascular Risk ◽  
Risk Patient ◽  
High Cardiovascular Risk ◽  
Pcsk9 Inhibitors ◽  
Mcardle's Disease ◽  
Mcardle’S Disease

scholarly journals Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk

2018 ◽  
Author(s):  
Paulo Eduardo Ballvé Behr ◽  
Emilio Hideyuki Moriguchi ◽  
Iran Castro ◽  
Luiz Carlos Bodanese ◽  
Oscar Pereira Dutra ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
High Cardiovascular Risk ◽  
Pcsk9 Inhibitors ◽  
Very High

Treatment with PCSK9 inhibitors induces a more anti-atherogenic HDL lipid profile in patients at high cardiovascular risk

2020 ◽  
Vol 135 ◽  
pp. 106804
Author(s):  
Cécile Ingueneau ◽  
Tim Hollstein ◽  
Thomas Grenkowitz ◽  
Jean-Bernard Ruidavets ◽  
Ursula Kassner ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
Lipid Profile ◽  
High Cardiovascular Risk ◽  
Pcsk9 Inhibitors

Quality Of Life Improvement In High And Very High Cardiovascular Risk Patients Treated With Pcsk9 Inhibitors

2019 ◽  
Vol 287 ◽  
pp. e199
Author(s):  
A. Cesaro ◽  
F. Gragnano ◽  
F. Fimiani ◽  
E. Moscarella ◽  
I. Pariggiano ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cardiovascular Risk ◽  
High Cardiovascular Risk ◽  
Pcsk9 Inhibitors ◽  
Risk Patients ◽  
Life Improvement ◽  
Very High
Sign in / Sign up

Export Citation Format

Share Document